SCHEMBL24609748

SCHEMBL24609748

c1ccc(-c2ccc3ccc4ccc(-c5cccc(-c6ccc7c(c6)nc(-c6ccccc6)c6c8ccc(-c9ccc%10ccccc%10c9)nc8ccc76)c5)nc4c3n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ CYP17A1 P05093 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ SRC P12931 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ ADORA2A P29274 3/20 0.34
▸ ADORA1 P30542 3/20 0.34
▸ KDM4E B2RXH2 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HSD17B1 P14061 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24609717 0.95 PARP1 (0.36) MEN1KMT2APARP1TP53CYP1A2
SCHEMBL24609599 0.94 CYP1A1 (0.38) CYP1A1CYP1B1MEN1KMT2APARP1
SCHEMBL24609916 0.94 CYP1A1 (0.39) CYP1A1CYP1B1MEN1KMT2APARP1
SCHEMBL24609923 0.93 CYP1A1 (0.40) CYP1A1CYP1B1MEN1KMT2APARP1
SCHEMBL24609747 0.92 TDO2 (0.37) MEN1KMT2APARP1TP53CYP1A2
SCHEMBL24609743 0.90 TOP1 (0.41) PARP1TP53HIF1AKDM4EALDH1A1
SCHEMBL24609738 0.90 DHODH (0.39) MEN1KMT2APARP1KDM4EALDH1A1
SCHEMBL24609631 0.90 PARP1 (0.36) MEN1KMT2APARP1KDM4EALDH1A1
SCHEMBL24609822 0.89 CYP1A1 (0.40) CYP1A1CYP1B1MEN1KMT2APARP1
SCHEMBL24609619 0.88 PARP1 (0.37) CYP1A1CYP1B1MEN1KMT2APARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213098-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213098-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 CYP1A1 2/4885CYP1B1 3/4885MEN1 343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback